nepafenac 1 MG/ML Ophthalmic Suspension
- RxCUI
- 578044
- RxNorm name
- nepafenac 1 MG/ML Ophthalmic Suspension
- Display name
- nepafenac 1 MG/ML Ophthalmic Suspension
- Full name
- nepafenac 1 MG/ML Ophthalmic Suspension
- Term type
- SCD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:48
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NEVANAC | NEPAFENAC | Harrow Eye, LLC | 11b9a0cf-2a70-17ef-e063-6394a90a5d9e | 2024-11-05 | Warnings, Adverse reactions | 578044 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 11b9a0cf-2a70-17ef-e063-6394a90a5d9e | nepafenac 1 MG/ML Ophthalmic Suspension | SCD | 3 | These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005 | 20241105 |
| 11b9a0cf-2a70-17ef-e063-6394a90a5d9e | nepafenac 0.1 % Ophthalmic Suspension | PSN | 3 | These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005 | 20241105 |
| 11b9a0cf-2a70-17ef-e063-6394a90a5d9e | nepafenac 0.1 % Ophthalmic Suspension | SY | 3 | These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005 | 20241105 |
| a2909252-c5f1-421f-9073-b7be90b45b51 | nepafenac 0.1 % Ophthalmic Suspension | PSN | 2 | These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005 | 20230419 |
| a2909252-c5f1-421f-9073-b7be90b45b51 | nepafenac 0.1 % Ophthalmic Suspension | SY | 2 | These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005 | 20230419 |
| a2909252-c5f1-421f-9073-b7be90b45b51 | nepafenac 1 MG/ML Ophthalmic Suspension | SCD | 2 | These highlights do not include all the information needed to use NEVANAC safely and effectively. See full prescribing information for NEVANAC. NEVANAC ® (nepafenac ophthalmic suspension) 0.1%, for topical ophthalmic use Initial U.S. Approval: 2005 | 20230419 |
| 52fe0332-388a-451c-b759-97e760883837 | nepafenac 0.1 % Ophthalmic Suspension | SY | 1 | These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 2005 | 20110831 |
| 52fe0332-388a-451c-b759-97e760883837 | nepafenac 1 MG/ML Ophthalmic Suspension | SCD | 1 | These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 2005 | 20110831 |
| 52fe0332-388a-451c-b759-97e760883837 | nepafenac 0.1 % Ophthalmic Suspension | PSN | 1 | These highlights do not include all the information needed to use nevanac safely and effectively. See full prescribing information for nevanac. nevanac (nepafenac) suspension for ophthalmic use Initial U.S. Approval: 2005 | 20110831 |